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Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. In the present study, the function of amyloid precursor 
protein (APP) in modulating capacitive calcium entry (CCE), a refilling mechanism for depleted intracellular calcium stores, was 
investigated. CCE in neural 2a (N2a) cells stably expressing wild-type human APP was lower than in wild-type N2a cells, while 
CCE in APP knockout mouse embryonic fibroblast (MEF) cells was higher than in their wild-type counterparts. We demonstrate 
that wild-type APP depresses CCE. Furthermore, using N2a cells transfected with C-terminal APP fragments, we show that these 
fragments anchored in the cell membrane play an important role in CCE depression. 
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Amyloid precursor protein (APP) plays an important role in 
the pathophysiology of Alzheimer’s disease (AD), one of 
the most common neurodegenerative diseases affecting an 
increasing population worldwide [1,2]. APP can be pro-
cessed to generate proteolytic fragments through two dis-
tinct intracellular metabolic pathways. One is the non-  
amyloidogenic pathway, through which APP is cleaved by 
α-secretase, generating a large extracellular soluble APPα 
(sAPPα) and an intracellular C-terminal fragment (C83). 
The other is the amyloidogenic pathway, where APP is se-
quentially cleaved by β- and γ-secretase. β-Secretase cleav-
age produces extracellular soluble APPβ (sAPPβ) and C99 
fragments. The C99 fragment is further cleaved by 
γ-secretase to liberate the amyloid intracellular domain 
(AICD) and β-amyloid peptide (Aβ), which is deposited to 
form senile plaques in AD brains [1,3]. 
APP gene mutations have long been known to be major 
causes of the familial form of AD, and have attracted exten-
sive study [4,5]. Although the relationship between APP 
mutations and AD is already well established, the normal 
physiological functions of APP are still unclear. An in-
creasing body of evidence suggests that APP might be in-
volved in various cellular activities, including intracellular 
signal transduction, gene expression, cellular organelle 
function, axonal transport and synaptic plasticity [6–11]. In 
addition, recent studies have shown that virtually every 
proteolytic fragment of APP, including the secreted ecto-
domain, Aβ, C99 and AICD, can differentially modulate 
calcium signaling [12], and even lead to intracellular cal-
cium dyshomeostasis [13,14]. 
Capacitive calcium entry (CCE) is a store deple-
tion-activated calcium influx pathway [15], through which 
calcium enters the cells via store-operated calcium channels 
(SOCs) on the plasma membrane, replenishing ER calcium 
stores [13]. CCE was first identified as a major route of cal-
cium influx in non-excitable cells, but is now known to be 
present in smooth muscle cells, neurons and other excitable 
cells as well [16–19]. CCE prolongs the duration of intra-
cellular Ca2+ elevation and assists in refilling depleted ER 
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Ca2+ stores [20]. As a major mechanism of cellular Ca2+ 
signaling, CCE has been implicated in a number of neuro-
pathological conditions, including AD [19]. It has been re-
ported that knockout of presenilins (PS1 and PS2) alters ER 
calcium stores [21]. In addition, their corresponding familial 
AD mutations act as negative regulators of CCE, which 
might contribute to the onset of dementia [22–24].  
In contrast to extensive studies on the relationship be-
tween presenilins and CCE, the roles of full-length APP and 
its proteolytic derivatives on CCE regulation remain to be 
elucidated. We therefore investigated the regulatory effects 
of APP on CCE. Time-lapse recordings of intracellular Ca2+ 
signals were performed in both neural 2a (N2a) cells and 
mouse embryonic fibroblast (MEF) cells. N2a cells stably 
expressing wild-type human APP695 (APPwt) and APP 
gene knockout MEF cells (APP−/−) were used here to assess 
the effects of APP on CCE modulation. Our results demon-
strate that CCE in N2a APPwt cells is lower than in N2a 
wild-type (WT) cells, which indicates that wild-type APP 
overexpression can depress CCE. Moreover, CCE in MEF 
APP−/− cells was elevated compared with control cells, fur-
ther supporting a negative modulatory role of APP in the 
CCE pathway. To examine whether the inhibitory effect of 
APP on CCE was mediated by the full-length protein and/or 
its fragments, we performed genetic and pharmacological 
manipulations on N2a cells. In accordance with results pre-
viously published by our group [25], abrogation of Aβ re-
sulted in a further suppression of CCE in N2a APPwt cells, 
implying its potentiating effect on CCE. Cell culture me-
dium treatment experiments revealed that the extracellular 
soluble APP fragments were unable to depress CCE. Com-
pared with these fragments, CCE was significantly lower in 
N2a cells transfected with C-terminal APP fragments, sug-
gesting that fragments anchored to the cell membrane might 
be responsible for the CCE suppressing effect. 
1  Materials and methods 
1.1  Antibodies and chemicals 
Mouse monoclonal antibody 6E10, recognizing APP, was 
obtained from Signet Laboratory (USA). Antibody 4G8 
against Aβ and rabbit polyclonal antibody recognizing the 
C-terminal of APP were from Sigma (USA). Goat anti- 
mouse IgG and goat anti-rabbit IgG, conjugated with alka-
line phosphatase, as well as N-[N-(3,5-difluorophenacetyl)- 
L-alanyl]-S-phenylglycine t-butyl ester (DAPT) were from 
Sigma. G418 was from Amresco (USA). 
1.2  Cell cultures and transfection 
The cells and vectors, including mouse neural 2a (N2a) cells 
stably expressing wild-type human APP695 (APPwt), Swe-
dish mutant of APP (APPswe), and their wild-type (WT) 
controls, i.e. blank vector-transfected N2a cells, were gen-
erous gifts from Dr. Huaxi Xu in the Burnham Institute, 
USA [25]. The cell culture medium for these cells contained 
equal parts of DMEM (Gibco, USA) and Opti-MEM (Gib-
co), as well as 5% fetal bovine serum (FBS) and 0.1% peni-
cillin & streptomycin. Embryonic fibroblasts isolated from 
APP knockout mice (APP−/−) and their wild-type counter-
parts (APP+/+) were cultured in DMEM containing 10% 
FBS and 0.1% penicillin & streptomycin [8]. Transfection 
of C99 was performed using lipofectamine 2000 reagent 
(Invitrogen, USA). The transfected cells were screened with 
300 µg/mL G418 for more than 10 d. 
1.3  Calcium imaging 
Intracellular [Ca2+] measurements were performed using the 
indicator Fluo3/AM (Calbiochem, USA). Fluo3/AM was 
solubilized in DMSO, aliquoted and stored at –20°C. Cells 
were loaded with 5 μmol/L Fluo3/AM in HBSS (145 
mmol/L NaCl, 2.5 mmol/L KCl, 1 mmol/L MgCl2, 20 
mmol/L HEPES, 10 mmol/L Glucose, 50 μmol/L EGTA) 
containing bovine serum albumin (1%) at 37°C for 30 min. 
After 30 min of washing, they were viewed using an upright 
microscope (BX61, Olympus, Japan). Fluorescence intensi-
ties were acquired at 3-s intervals. Digital images were col-
lected using a CCD camera (CoolSNAP HQ, Photometrics, 
USA) with a 20× water immersion objective, and subse-
quently analyzed using MetaMorph (Molecular Devices, 
USA). Each experiment was performed on at least four cul-
tures. Experiments were performed at room temperature. 
1.4  Western blotting analysis 
Cultured cells were collected and treated with cell lysis 
buffer. A commercially available BCA kit (Pierce, USA) 
was used to determine protein concentrations. Samples 
containing similar amounts of protein were diluted with 4× 
SDS-PAGE loading buffer and boiled at 100°C for 5 min. 
After separation by 10% SDS-PAGE, the protein samples 
were electrophoretically transferred onto a piece of nitro-
cellulose membrane. Primary antibodies, 6E10 (1:1000 
dilution) or C-terminal APP antibody (1:1000 dilution), 
were then incubated with the membrane at 4°C overnight. 
Immunoreactive bands on the membrane were then detected 
by incubating with alkaline phosphatase conjugated goat- 
anti-mouse IgG (1:10000 dilution) or goat-anti-rabbit IgG 
(1:5000 dilution). For C99 detection, Tris-Tricine SDS- 
PAGE was performed. Most of the procedures were the 
same as SDS-PAGE, except that for Tris-Tricine SDS- 
PAGE, the samples were diluted with 4× Tris-Tricine SDS- 
PAGE sample buffer and proteins were separated using 
20% Tris-Tricine gels. 
1.5   Reverse transcription PCR 
Total RNA was extracted from cells using the Trizol RNA 
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extraction reagent (Invitrogen). First-strand cDNA was 
synthesized from 2 μg of total RNA in a final volume of 20 
μL using a first-strand cDNA synthesis kit (Toyoba, Japan). 
PCR reaction was conducted using 3 μL aliquots of the RT 
reaction and specific primers for TRPC1–7, TRPV6 and 
STIM1 mouse sequences [26,27]. Forward and reverse pri-
mers were as follows: TRPC1, 5′-CAAGATTTTGGGAAA- 
TTTCTGG-3′ and 5′-TTTATCCTCATGATTTGCTAT-3′; 
TRPC2, 5′-GACGACATGATCCGGTTCATGTTC-3′ and 
5′-CTCGATCTTCTGGAAGGAGTTGGTG-3′; TRPC3, 5′- 
GTGGGCAATAATACTCCTAA-3′ and 5′-CATGACCGC- 
CTAGCTTAA-3′; TRPC4, 5′-TCTGCAGATATCTCTGG- 
GAAGGATG-3′ and 5′-AAGCTTTGTTCGAGCAAATTT- 
CCATTC3′; TRPC5, 5′-ATCTACTGCCTAGTACTACTG- 
GCT-3′ and 5′-CAGCATGATCGGCAATGAGCTG-3′; 
TRPC6, 5′-AAAGATATCTTCAAATTCATGGTC-3′ and 
5′-CACGTCCGCATCATCCTCAATTTC-3′; TRPC7, 5′- 
GACTACTTCTGCAAGTGCAATGAGTGC-3′ and 5′-TT- 
CCACAAGTGTAGCACGTACTCCC-3′; TRPV6, 5′-ATC- 
CGCCGCTATGCACA-3′ and 5′-AGTTTTTCTCCTGAA- 
TCTTTTTCCAA-3′; STIM1, 5′-AGACATTTATGGCGT- 
TGAA-3′ and 5′-GAAAGGAAGGGAGGTGAA-3′. PCR 
was performed using Expand High Fidelity Taq polymerase 
(Promega, USA). Thermocycling consisted of 35 cycles of 
denaturation at 94°C for 45 s, annealing at 53 to 62°C (op-
timized for each fragment amplified) for 45 s and extension 
at 72°C for 15 s, followed by a final extension at 72°C for 
10 min. 
1.6  sAPP ELISA 
sAPP levels in the media of N2a APPwt and N2a APPswe 
cells were assessed using a sandwich enzyme-linked im-
munosorbent assay (ELISA) kit (Covance, USA). Briefly, 
50 L of concentrated cell culture medium or standard con-
trols from the kit were added to microtiter plates covered 
with primary antibody at 4°C overnight. Secondary anti-
body conjugated with HRP was then applied and incubated 
for another 1 h at room temperature. After washing, the wells 
were loaded with chemiluminescence substrate solution. The 
plate was then read immediately with a luminometer. 
1.7  Statistical analysis 
Data were presented as mean ± SD. Student’s t-test was 
used to perform statistical analysis of the results. P < 0.05 
was considered significant. 
2   Results 
2.1  Wild-type APP overexpression attenuates CCE 
CCE was measured in N2a WT cells in parallel with N2a 
cells stably expressing wild-type human APP (APPwt) 
(Figure 1(a)). To induce CCE, cells were first incubated in 
Ca2+-free medium containing cyclopiazonic acid (CPA) to 
deplete ER Ca2+ stores, and subsequently replenished with 
Ca2+-containing medium (1.8 mmol/L) to facilitate calcium 
entry [22–24]. Figure 1(b) shows intracellular calcium 
changes in two representative experiments carried out with 
N2a WT (continuous trace) and APPwt (dashed trace) cells. 
The average peak amplitude of CCE, expressed as normal-
ized ratio above baseline, was significantly decreased in 
N2a APPwt cells compared with N2a WT cells (Figure 
1(c)), implying that wild-type APP, and/or some of its 
fragments, might depress CCE. 
CCE in the APP gene knockout MEF cells (APP−/−) was 
also compared with that in wild-type MEF cells (APP+/+). 
Significantly greater CCE was found in MEF APP−/− cells 
compared with MEF APP+/+ control cells (Figure 1(d),(e)). 
This suggests that CCE is apparently enhanced by the ab-
sence of APP, indicating that APP might be necessary to 
maintain CCE at normal levels. Since APP can be processed 
by secretases to produce several fragments in addition to 
full-length APP, levels of APP fragments may also be ele-
vated in N2a APPwt cells, and down-regulated in MEF 
APP−/− cells. These results suggest that full-length APP 
and/or its fragments have the ability to suppress CCE. 
2.2  Abrogation of Aβ further depresses CCE in N2a 
APPwt cells 
The suppression of CCE in N2a APPwt cells could be me-
diated by full-length APP and/or its fragments. To discrim-
inate between these possibilities, N2a cells were manipu-
lated with gene transfection or pharmacological treatments 
before CCE assessments. As mentioned above, our previous 
results demonstrated that Aβ can potentiate CCE in N2a 
cells stably expressing Swedish mutant APP (APPswe) [25]. 
This finding has been bolstered by the results obtained in 
N2a APPwt cells here. Aβ antibody 4G8, which can com-
pletely block the effect of extracellular Aβ, was added to the 
culture medium of N2a APPwt cells for 24 h (at 0.05%, v/v). 
Following this treatment, CCE in N2a APPwt cells was 
further depressed compared with N2a APPwt controls not 
treated with 4G8 (Figure 2(a),(b)). Furthermore, a 24 h in-
cubation of N2a APPwt cells with 2 μmol/L DAPT, which 
can inhibit γ-secretase activity and therefore stop the secre-
tion of Aβ, had a similar effect on CCE (Figure 2(c)–(e)). 
Abrogation of Aβ in N2a APPwt cells resulted in a further 
attenuation of CCE compared with either N2a WT or AP-
Pwt control cells (Figure 2(b),(e)). Given the CEE-enhanc- 
ing effect of Aβ, we propose that full-length APP and/or its 
proteolytic derivatives other than Aβ might mediate the 
depression of CCE, with a more powerful impact. 
2.3  Membrane-anchored APP fragments depress CCE 
APP can be processed by β-secretase or α-secretase, releas-
ing large soluble fragments, sAPPβ and sAPPα, into the   
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Figure 1  CCE in N2a APPwt cells was lower than in N2a WT controls. (a) APP expression levels were higher in N2a APPwt cells than in WT cells. Cell 
lysates from different cells were analyzed by Western blotting with anti-APP monoclonal antibody (6E10) (upper panel); (b) representative time courses of 
CCE in N2a WT and APPwt cells; (c) the average peak amplitudes of CCE in N2a WT and APPwt cells; (d) representative time courses of CCE in APP 
knockout MEF cells (APP−/−) and wild-type MEF cells (APP+/+); (e) the average peak amplitudes of CCE in MEF APP−/− and APP+/+ cells. n, number of cells; 
*P < 0.05, **P < 0.01. 
extracellular space. To determine if these secreted frag-
ments are involved in the depression of CCE in N2a APPwt 
cells, we performed a number of experiments. Culture me-
dia were collected from N2a APPswe cells, which mainly 
contain sAPPβ, after a 24-h incubation period, as well as 
from N2a APPwt cells, which mainly produce sAPPα (Fig-
ure 3(a)). N2a WT cells were then incubated with culture 
medium from N2a APPswe or APPwt cells, separately, in 
the presence of 0.1% mouse anti-Aβ antibody 4G8 to abro-
gate the effect of Aβ. After 24 h, CCE was measured in both 
of these N2a WT cultures. No obvious changes in CCE 
were observed in N2a WT cells when they were incubated 
with these media containing different quantities of sAPPα 
and sAPPβ (Figure 3(b),(c)), suggesting that the secreted 
fragments of APP may not participate in CCE depression in 
N2a APPwt cells. 
The effect of the membrane-anchored APP fragments on 
CCE was then studied in N2a cells. To examine the role of 
C-terminal APP fragments in the regulation of CCE, N2a 
cells were transfected with a C99 construct (APPCTF) or an 
empty vector control before CCE measurements. The 300 
μg/mL G418 was used to screen the cell lines for a period 
greater than 10 d. Western blotting analysis showed that 
both C99 and C83 were overexpressed in the cell line (Fig-
ure 3(d)). Before CCE estimation, N2a APPCTF cells were 
treated with 2 μmol/L DAPT for 24 h to exclude the influ-
ence of Aβ or AICD fragments generated endogenously. 
The average peak amplitude of CCE was found to be dra-
matically attenuated in N2a APPCTF cells (Figure 3(e),(f)). 
These results demonstrate an important role of C-terminal 
APP fragments, C99 and/or C83, in CCE depression. 
2.4  CCE depression in N2a APPwt cells is independent 
of the transcription of store-operated calcium channels 
(SOCs) 
To clarify the mechanism underlying the depressed CCE in 
N2a APPwt cells, we examined the expression of SOCs in 
N2a APPwt and WT cells. RT-PCR was used to measure 
transcription of the SOCs recently identified in animal cells 
[26,27], including TRPC 1–7, TRPV 6 and STIM1. Four of 
these were found to be transcribed in both N2a WT and 
APPwt cells (Figure 4(a)). However, none showed remark-
able differences at the mRNA level between N2a APPwt  
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Figure 2  Removal of Aβ further depresses CCE. (a) Representative time courses of CCE in N2a WT cells and APPwt cells with or without Aβ antibody 
treatment; (b) the average peak amplitudes of CCE in N2a WT and APPwt cells with or without Aβ antibody treatment; (c) representative time courses of 
CCE in N2a WT cells with or without DAPT treatment; (d) representative time courses of CCE in N2a APPwt cells with or without DAPT treatment; (e) the 
average peak amplitudes of CCE in N2a WT and APPwt cells with or without DAPT treatment. n, number of cells; **P < 0.01. 
and WT cells (Figure 4(b)). This suggests that transcrip-
tional regulation of store-operated channels is not involved 
in the mechanism by which the APP C-terminal fragments 
depress CCE. 
3  Discussion 
APP, a type I intrinsic membrane protein, is widely ex-
pressed and distributed in the central nervous system and 
peripheral tissues [28]. While the roles of APP mutations in 
the pathogenesis of AD have been thoroughly studied, the 
normal physiological functions of the protein remain un-
clear and debatable [29,30]. Recently published reports 
highlight the importance of APP in various cellular pro-
cesses, ranging from intracellular signal transduction to 
synaptic plasticity [6,11]. APP can be processed by α-, β- 
and γ-secretases to generate various proteolytic products, 
including secreted APPs, AICD and Aβ. The effects of 
some of these APP proteolytic derivatives on cellular cal-
cium homeostasis have been studied [13,14]. However, 
whether APP proteins and/or its fragments regulate CCE 
remains to be clarified. CCE is one of the primary mecha-
nisms regulating calcium influx into the cytoplasm. It regu-
lates a number of vital cellular processes, such as gene 
transcription, cell cycle regulation, apoptosis and calcium 
oscillation [15,18,31]. Disturbed CCE signaling has been 
found to play a role in the neurodegenerative process  
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Figure 3  The effects of secreted and C-terminal fragments of APP on CCE. (a) Relative contents of sAPP and sAPP in the media of N2a APPwt and 
APPswe cells. Media from different cell cultures were collected and analyzed by ELISA to detect sAPP (i, n = 3) and by western blotting with antibody 
6E10 to detect sAPP (ii, which is representative of three independent experiments); (b) representative time courses of CCE in N2a WT cells treated with 
N2a APPwt or APPswe medium; (c) the average peak amplitudes of CCE in N2a WT cells treated with N2a APPwt or APPswe cell culture medium; (d) 
APP-CTF fragment expression levels were higher in N2a cells transfected with the C-terminal APP construct (APPCTF). Cell lysates from different cells were 
analyzed by western blotting with a C-terminal APP-specific antibody; (e) representative time courses of CCE in N2a WT and APPCTF cells; (f) the average 
peak amplitudes of CCE in N2a WT and APPCTF cells. n, number of cells; **P < 0.01. 
underlying AD [22–24]. 
In this study, we investigated the effect of APP on CCE. 
We found that wild-type human APP overexpression can 
depress CCE. This finding may provide substantial insight 
into the physiological functions of APP. However, a study 
by Herms et al., which focused on the modulatory role of 
mutant presenilin-1 on CCE, implied that APP knockout 
does not significantly change CCE [23], which is not in 
agreement with our findings. This discrepancy could be 
because of differences in experimental protocols and/or the  
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Figure 4  APP does not affect mRNA levels of store-operated calcium 
channels. (a) mRNA expression levels of representative store-operated 
calcium channels in N2a WT cells determined using RT-PCR; (b) mRNA 
expression levels of four store-operated calcium channels in N2a WT and 
APPwt cells. 
model cells used. 
As APP is processed by secretases to produce several 
fragments, the CCE depressing effect of wild-type APP 
observed here could be the combined effect of full-length 
APP and/or its fragments. The effects of APP fragments on 
CCE were therefore investigated here. We have already 
demonstrated the CCE-potentiating effect of Aβ, the most 
toxic fragment of APP [25,32]. CCE in N2a APPwt cells 
could be further depressed by treatment with Aβ antibody or 
DAPT, suggesting that full-length APP and/or APP frag-
ments other than Aβ can depress CCE in N2a APPwt cells, 
and this depressing effect is even stronger than the CCE- 
potentiating effect of Aβ.  
The extracellular secreted fragments of APP have been 
demonstrated to exhibit neuroprotective properties, such as 
preventing tau hyperphosphorylation, protecting against 
oxidative impairment and enhancing memory [12,33,34]. 
They might attenuate the calcium response to protect hip-
pocampal neurons from excitotoxicity caused by cellular 
insults, such as Aβ or excessive glutamate [35,36]. Secreted 
APPs may also protect cells with PS1 mutations by stabi-
lizing intracellular calcium levels [37]. However, we failed 
to find any significant effect of these secreted APPs on CCE 
response (it is worth noting that the initial rate of CCE in 
N2a WT cells treated with APPwt medium was somewhat 
lower than in N2a WT controls despite the unchanged av-
erage peak amplitude; this observation requires further 
study for clarification). These results prompted us to inves-
tigate the action of C-terminal APP fragments on CCE in 
N2a cells by transfecting them with C99 constructs. C99 
transfection induced a lower CCE compared with control 
cells. As C99 fragments are the obligatory precursors of Aβ 
peptides, the cleavage of C99 fragments by γ-secretase was 
inhibited using DAPT before CCE measurement. Therefore, 
it appeared that C99 fragments mediated the observed alter-
ations in CCE signaling. Since C99 can be cleaved by 
α-secretase to generate C83 fragments, both C99 and C83 
are overexpressed in N2a APPCTF cells. We were therefore 
unable to determine whether C99 or C83, or both, contrib-
ute to the depression of CCE in N2a APPCTF cells. 
The mechanisms of CCE regulation are complex [38]. 
Our recently published data indicate that there is no signifi-
cant difference in ER calcium store content between N2a 
APPwt and WT control cells [39]. Therefore, other mecha-
nisms must be responsible for the modulation of CCE by 
C-terminal APP fragments. One of these might be altered 
expression of store-operated channels. To examine this pos-
sibility, we examined the transcriptional levels of several 
SOCs in N2a WT and APPwt cells. Among the SOCs ex-
pressed in both N2a WT and APPwt cells, we failed to find 
any obvious differences in mRNA expression between these 
two cell lines. Thus, the inhibitory action of C-terminal APP 
fragments on CCE is likely to be caused by an alternative 
mechanism. Further studies are required to clarify the mo-
lecular mechanisms underlying this modulation in detail. 
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